{
    "2021-09-02": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Breakout Watch: Medical Breakthroughs Drive 105% Earnings Growth For Abbott Stock",
                "features": {
                    "keywords": [
                        "Medical Breakthroughs",
                        "Earnings Growth",
                        "Abbott Stock"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Abbott Expands Peripheral Vascular Offerings with Acquisition of Walk Vascular, LLC",
                "features": {
                    "keywords": [
                        "Abbott",
                        "Peripheral Vascular",
                        "Acquisition",
                        "Walk Vascular"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "This May Be Abbott's Billion-Dollar Opportunity",
                "features": {
                    "keywords": [
                        "Billion-Dollar",
                        "Opportunity",
                        "Abbott"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Abbott (ABT) Heart Failure Device Study Outcome Favorable (Revised)",
                "features": {
                    "keywords": [
                        "Heart Failure Device",
                        "Study Outcome",
                        "Favorable",
                        "Abbott"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}